---
title: "Gaudium IVF and Women Health Ltd (GAUDIUMIVF) — Share Price, Financials & Analysis"
symbol: "GAUDIUMIVF"
company: "Gaudium IVF and Women Health Ltd"
canonical: "https://tapetide.com/stocks/GAUDIUMIVF"
isin: "INE0P8B01020"
nse_symbol: "GAUDIUMIVF"
bse_code: "544709"
sector: "Healthcare"
industry: "Healthcare Service Provider"
market_cap_cr: 827.15
generated_at: "2026-09-13T18:26:30.018Z"
---

# Gaudium IVF and Women Health Ltd (GAUDIUMIVF)

Canonical page: https://tapetide.com/stocks/GAUDIUMIVF

## Company

- **NSE Symbol:** GAUDIUMIVF
- **BSE Code:** 544709
- **ISIN:** INE0P8B01020
- **Sector:** Healthcare
- **Industry:** Healthcare Service Provider
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2026-02-27
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** gaudiumivfcentre.com

## About

Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]

## Latest Price

- **Price:** ₹117.75
- **Change:** +2.49 (+2.16%)
- **Open:** ₹115.88
- **Day High:** ₹121.02
- **Day Low:** ₹111.75
- **Previous Close:** ₹115.26
- **Volume:** 241339
- **As Of:** 2026-09-11T09:59:43+00:00

## Key Fundamentals

Observed at 2026-09-11T04:35:17.741673Z.

- **Market Cap:** ₹827.15 Cr
- **Classification:** Microcap
- **P/E (reported):** 36
- **P/E (TTM):** 33.55
- **EPS (TTM):** ₹3.51
- **Book Value:** ₹20.92
- **Price to Book:** 5.47
- **Dividend Yield:** 0%
- **ROE:** 41.31%
- **ROCE:** 53.09%
- **Debt to Equity:** 0.16
- **Revenue (yearly):** ₹104.36 Cr
- **Net Income:** ₹24.46 Cr
- **EBITDA:** ₹37.71 Cr
- **52-Week High:** ₹163.18
- **52-Week Low:** ₹69.18
- **RSI (14):** 41.95

## Key Insights

### Strengths

- Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 187 days.
- Working capital days have increased from 39.9 days to 90.9 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 153.49% | -63.44% | — |
| ebitda margin growth | -71.77% | -11.61% | -25.17% | -2.18% |
| net income growth | -78.57% | 28.06% | 22% | 177.95% |
| revenue growth | -32.79% | 46.99% | 33% | 23.38% |
| roce | -75.83% | -15.64% | -23.08% | 72.56% |
| roe | -78.71% | -17.21% | 50.24% | -30.57% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 14.42 | 26.92 | 17.76 | 31.73 | 24.51 | 30.35 | 19.38 |
| Expenses | 8.76 | 18.2 | 12.61 | 17.96 | 17.95 | 18.18 | 16.95 |
| Operating Profit | 5.66 | 8.72 | 5.15 | 13.77 | 6.56 | 12.17 | 2.43 |
| OPM % | 39.25 | 32.39 | 29 | 43.4 | 26.76 | 40.1 | 12.54 |
| Other Income | 0 | 0.23 | 0 | 0.15 | 0.1 | 0.18 | 1.12 |
| Interest | 0.39 | 0.43 | 0.5 | 0.51 | 1.2 | 1.29 | 0.38 |
| Depreciation | 0.58 | 0.36 | 0.61 | 0.61 | 0.49 | 0.64 | 0.72 |
| Profit before tax | 4.69 | 8.16 | 4.04 | 12.8 | 4.97 | 10.42 | 2.45 |
| Tax % | 27.72 | 20.96 | 24.01 | 26.64 | 26.96 | 19.77 | 27.76 |
| Net Profit | 3.4 | 6.46 | 3.07 | 9.38 | 3.63 | 8.36 | 1.78 |
| EPS in Rs | 0.55 | 1.05 | 0.5 | 1.53 | 0.59 | 1.15 | 0.24 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 37 | 44 | 48 | 71 | 104 | 106 |
| Expenses | 23 | 24 | 28 | 42 | 67 | 71 |
| Operating Profit | 14 | 20 | 19 | 29 | 38 | 35 |
| OPM % | 37 | 46 | 41 | 41 | 36 | 33 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 2 |
| Interest | 1 | 0 | 1 | 2 | 3 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 3 | 2 |
| Profit before tax | 12 | 18 | 17 | 25 | 32 | 31 |
| Tax % | 26 | 26 | 38 | 25 | 24 | — |
| Net Profit | 9 | 14 | 10 | 19 | 24 | 23 |
| EPS in Rs | 89.17 | 136.54 | 104.22 | 3.12 | 3.36 | 3.51 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.99 | 0.99 | 0.99 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 116 |
| Borrowings | 6 | 12 | 17 | 21 | 25 |
| Other Liabilities | 3 | 2 | 7 | 22 | 16 |
| Total Liabilities | 18 | 37 | 51 | 89 | 193 |
| Fixed Assets | 4 | 18 | 19 | 18 | 30 |
| CWIP | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 5 |
| Other Assets | 14 | 18 | 32 | 58 | 158 |
| Total Assets | 18 | 37 | 51 | 89 | 193 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -1 | 24 | 3 | 9 | 7 |
| Cash from Investing Activity | -1 | -16 | -5 | -15 | -88 |
| Cash from Financing Activity | 3 | 5 | -1 | 2 | 82 |
| Net Cash Flow | 0 | 13 | -3 | -5 | 2 |
| Free Cash Flow | -2 | 9 | 1 | 0 | 5 |
| CFO/OP | 13 | 141 | 27 | 46 | 51 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 65 | 8 | 104 | 170 | 187 |
| Inventory Days | 29 | 111 | 168 | 175 | 38 |
| Days Payable | 114 | 77 | 62 | 338 | 133 |
| Cash Conversion Cycle | -20 | 41 | 210 | 7 | 92 |
| Working Capital Days | 61 | -52 | -15 | 44 | 91 |
| ROCE % | — | 76 | 45 | 49 | 29 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- |
| Promoters | 99.98% | 71.29% | 71.29% |
| FIIs | 0% | 6.7% | 3.02% |
| DIIs | 0% | 2.62% | 2.22% |
| Government | 0% | 0% | 0% |
| Public | 0% | 14.67% | 16.78% |
| Others | 0.02% | 4.73% | 6.69% |
| No. of Shareholders | 7 | 19854 | 21910 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 3 / 9 / 7

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 119.33 | Sell |
| EMA (10) | 117.86 | Sell |
| SMA (20) | 118.06 | Sell |
| EMA (20) | 119.85 | Sell |
| SMA (50) | 128.16 | Sell |
| EMA (50) | 121.65 | Sell |
| SMA (100) | 120.48 | Sell |
| EMA (100) | 114.53 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 45.58 | Neutral |
| MACD (12,26,9) | -2.65 | Buy |
| Stochastic (14,3,3) | 28.36 | Neutral |
| ADX (14) | 17.7 | Neutral |
| Williams %R (14) | -69.33 | Neutral |
| ATR (14) | 5.64 | High Volatility |
| ROC (12) | 0.64 | Buy |
| Stoch RSI (14) | 46.63 | Neutral |
| UO (7,14,28) | 41.88 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28499a67-26db-4798-82e7-97b877fb1802.pdf) |
| 2026-09-03 | [Notice Of 11Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d7a1a6d-fd97-4fdc-a7b2-35ec98e6b929.pdf) |
| 2026-09-03 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c013209e-0c63-4df8-a285-eead765bb204.pdf) |
| 2026-09-03 | [Weblink Letter To Shareholders - Pursuant To Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3895212c-dc7a-4026-84f1-4aea01fe1d8f.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a410a302-bb5b-482e-b1c3-57399f4c7ff3.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec34d014-5ab1-40ef-b720-649c659cd62a.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Board Meeting Outcome For Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f645f6c-94f9-4636-aa5b-e62a0998872f.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dfbb56b-b4d1-4aad-bd82-29efa25c9747.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37bbbfa3-1b26-4c30-b552-617229a4a0b9.pdf) |
| 2026-08-13 | [Statement Of Deviation & Variation For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3d0b5f9-0ebe-42f8-9f44-2e5193d65037.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cfffdf5-f7f2-4972-90ae-61af57f28e5e.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5060b2f-4ae9-410c-9d10-e8021bba3377.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=636c05b7-07e3-4e14-ad56-4d751d43f061.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e25e2b2c-7c0e-43e1-ac00-78efe2477c38.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05e795f7-7968-4df5-86a6-a1a90fe40c14.pdf) |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c7c85a9-e913-4f29-9322-ec99102da5cb.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bc31b41-9a00-4092-bead-6987c11502a1.pdf) |
| 2026-05-28 | [Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75f07f28-f46e-44e9-8423-ebea6a0de9f9.pdf) |
| 2026-03-18 | [Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6427efe7-c7d6-422e-b022-242e290a26c5.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e25e2b2c-7c0e-43e1-ac00-78efe2477c38.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e25e2b2c-7c0e-43e1-ac00-78efe2477c38.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 Apr - Bombay High Court disposed Neomile petition on April 2, 2026; Justice Nitin Jamdar appointed sole arbitrator. | [Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vide Its Email Dated April 07 2026 Seeking Additional Details For Corporate Announcement Dated April 06 2026 Filed Under Regulation 30 Of SEBI (LODR) Regu 7 Apr - Bombay High Court disposed Neomile petition on April 2, 2026; Justice Nitin Jamdar appointed sole arbitrator.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7e02d9fe-ab1e-4c2e-9629-5574c82a18bf.pdf) |
| 6 Apr - Bombay High Court disposed IPO-related petition; Justice Nitin Jamdar appointed sole arbitrator on April 2, 2026. | [Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 (Listing Regulations) 6 Apr - Bombay High Court disposed IPO-related petition; Justice Nitin Jamdar appointed sole arbitrator on April 2, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f0d1c95c-11a6-4c85-8daa-264b6306f1dc.pdf) |
| 28 Mar - Trading window closed Apr 1, 2026 until 48 hours after FY2026 Q4 results announcement. | [Closure of Trading Window 28 Mar - Trading window closed Apr 1, 2026 until 48 hours after FY2026 Q4 results announcement.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4855113-b1e6-4e2b-8266-a5463dbbbdc7.pdf) |
| 2 Mar - Naveen Kumar appointed Company Secretary and Compliance Officer effective November 4, 2024. | [Intimation Under Regulation 6(1) Of The SEBI (LODR) Regulations 2015 2 Mar - Naveen Kumar appointed Company Secretary and Compliance Officer effective November 4, 2024.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bfc804b3-6de6-41fb-8026-00b2eb4dc780.pdf) |
| 2 Mar - Feb 28, 2026: Company filed Fair Disclosure Code under SEBI PIT Regulations; policy uploaded on company website. | [Intimation Under Regulation 8(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015 2 Mar - Feb 28, 2026: Company filed Fair Disclosure Code under SEBI PIT Regulations; policy uploaded on company website.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2cf77178-6aad-47ad-9260-dcea84417897.pdf) |
| 2 Mar - Appointed Bigshare Services Pvt Ltd as Registrar and Share Transfer Agent, effective Feb 27, 2026. | [Intimation Under Regulation 7(1) Of The SEBI (LODR) Regulations 2015 (SEBI Listing Regulations) 2 Mar - Appointed Bigshare Services Pvt Ltd as Registrar and Share Transfer Agent, effective Feb 27, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d0ea47c6-66af-4eb2-9168-a3c31aea7de6.pdf) |
| 2 Mar - 28-Feb-2026: Board authorized three KMPs (Chairperson/MD, CFO, Company Secretary) for materiality determination and stock exchange disclosures. | [Intimation Under Regulation 30(5) Of The SEBI (LODR) Regulations 2015 ("SEBI Listing Regulations") 2 Mar - 28-Feb-2026: Board authorized three KMPs (Chairperson/MD, CFO, Company Secretary) for materiality determination and stock exchange disclosures.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/16fb0c15-4bba-4700-8fd6-a13923713315.pdf) |
| 19 Mar - Q3 revenue ₹2,450.70L, Q3 net ₹363.05L; 9M net ₹1,614.90L; IPO raised ₹16,500.098L; listed Feb 27, 2026. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 19 Mar - Q3 revenue ₹2,450.70L, Q3 net ₹363.05L; 9M net ₹1,614.90L; IPO raised ₹16,500.098L; listed Feb 27, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c04f01e0-e651-4016-a45d-8b644543e642.pdf) |
| 18 Mar - March 18, 2026: Appointed Ram Rattan & Associates (Internal) and Suresh Nainwal & Co. (Secretarial) for FY2025-26. | [Announcement under Regulation 30 (LODR)-Change in Management 18 Mar - March 18, 2026: Appointed Ram Rattan & Associates (Internal) and Suresh Nainwal & Co. (Secretarial) for FY2025-26.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/244c5956-62b6-4714-84a0-3da2560aa4f9.pdf) |
| 18 Mar - Board approved unaudited Q3 and nine-month results; IPO of 20,886,200 shares at Rs79 raising Rs16,500.098 Lakhs; listed Feb 27, 2026. | [Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 18 Mar - Board approved unaudited Q3 and nine-month results; IPO of 20,886,200 shares at Rs79 raising Rs16,500.098 Lakhs; listed Feb 27, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6427efe7-c7d6-422e-b022-242e290a26c5.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:30.018Z.